Lyle J Arnold, Biocept's SR VP of R&D and CSO, recently acquired 50,000 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on July 06, 2016. Arnold now owns 60,714 shares of the company. Arnold operates out of San Diego, CA. Some additional info was provided as follows:
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!